In a Bad Year for Biotech Stocks, Deals and Vaccines Were Winners

WSJ2021-12-16

Biotech stocks have crumbled this year and a number of prominent hedge funds have suffered deep losses. But some biotech investors are thriving by focusing on mergers, short selling and Covid-19 ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
4